268 related articles for article (PubMed ID: 7159877)
1. Research design issues: antialuminum drug studies in Alzheimer's disease.
Shore D; Wyatt RJ
Clin Neuropharmacol; 1982 Dec; 5(4):337-43. PubMed ID: 7159877
[TBL] [Abstract][Full Text] [Related]
2. [Viewpoint on the methodology of drug trials affecting cognition of elderly patients].
Allain H; Bernard PM; Dartigues JF; Dérouesné C; Dubois B; Hugonot L; Laurent B; Léger JM; Malauzat D; Michel B
Encephale; 1994; 20(6):725-39. PubMed ID: 7875107
[TBL] [Abstract][Full Text] [Related]
3. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment.
Golden R
Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576
[TBL] [Abstract][Full Text] [Related]
4. Aluminum levels in brain in Alzheimer's disease.
Trapp GA; Miner GD; Zimmerman RL; Mastri AR; Heston LL
Biol Psychiatry; 1978 Dec; 13(6):709-18. PubMed ID: 737258
[TBL] [Abstract][Full Text] [Related]
5. NGF and the treatment of Alzheimer's disease.
Olson L
Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo and Alzheimer's disease: little or no different from placebo.
Prescrire Int; 2007 Oct; 16(91):205-7. PubMed ID: 17926840
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
8. Memory enhancement with oral physostigmine in Alzheimer's disease.
N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
[No Abstract] [Full Text] [Related]
9. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
Relkin NR
Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
[TBL] [Abstract][Full Text] [Related]
10. [Variability of efficacy measures in Alzheimer's disease].
Musicco M; Pettenati C; Caltagirone C
Ann Ist Super Sanita; 2005; 41(1):87-91. PubMed ID: 16037656
[TBL] [Abstract][Full Text] [Related]
11. Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.
Geldmacher DS
Expert Rev Neurother; 2004 Jan; 4(1):5-16. PubMed ID: 15853610
[TBL] [Abstract][Full Text] [Related]
12. A neuropsychological test battery for use in Alzheimer disease clinical trials.
Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
[TBL] [Abstract][Full Text] [Related]
13. Drugs for treatment of Alzheimer's disease.
Wilkinson D
Int J Clin Pract; 2001 Mar; 55(2):129-34. PubMed ID: 11321852
[TBL] [Abstract][Full Text] [Related]
14. Partnership between academia and industry for drug discovery in Alzheimer's disease.
Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
[TBL] [Abstract][Full Text] [Related]
16. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Gauthier S; Poirier J
Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
[No Abstract] [Full Text] [Related]
17. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.
van Reekum R; Simard M; Farcnik K
Can Fam Physician; 1999 Apr; 45():945-52. PubMed ID: 10216793
[TBL] [Abstract][Full Text] [Related]
18. Design issues in clinical trials.
Overall JE
Prog Clin Biol Res; 1989; 317():1291-9. PubMed ID: 2690096
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
